Australia markets closed

Creative Medical Technology Holdings, Inc. (CELZ)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
4.3500+0.0100 (+0.23%)
At close: 04:00PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 5.97M
Enterprise value -3.04M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)694.57
Price/book (mrq)0.65
Enterprise value/revenue 56.07
Enterprise value/EBITDA -1.45

Trading information

Stock price history

Beta (5Y monthly) 5.05
52-week change 3-24.14%
S&P500 52-week change 323.49%
52-week high 310.2812
52-week low 33.9300
50-day moving average 34.8110
200-day moving average 34.6911

Share statistics

Avg vol (3-month) 3207.66k
Avg vol (10-day) 33.32k
Shares outstanding 51.35M
Implied shares outstanding 61.36M
Float 81.32M
% held by insiders 12.71%
% held by institutions 12.66%
Shares short (30 Apr 2024) 420.49k
Short ratio (30 Apr 2024) 41.39
Short % of float (30 Apr 2024) 41.55%
Short % of shares outstanding (30 Apr 2024) 41.51%
Shares short (prior month 28 Mar 2024) 428.71k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:10
Last split date 312 June 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-59,061.30%

Management effectiveness

Return on assets (ttm)-23.49%
Return on equity (ttm)-40.34%

Income statement

Revenue (ttm)9k
Revenue per share (ttm)0.01
Quarterly revenue growth (yoy)-83.90%
Gross profit (ttm)N/A
EBITDA -5.53M
Net income avi to common (ttm)-5.29M
Diluted EPS (ttm)-3.7400
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)9.99M
Total cash per share (mrq)7.36
Total debt (mrq)14.19k
Total debt/equity (mrq)0.14%
Current ratio (mrq)27.66
Book value per share (mrq)7.53

Cash flow statement

Operating cash flow (ttm)-8.03M
Levered free cash flow (ttm)-6.37M